Home

Rafael Holdings, Inc. (RFL)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Rafael Holdings, Inc. (RFL)

Go deeper and ask any question about RFL

Company Performance

Current Price

as of Sep 13, 2024

$1.67

P/E Ratio

N/A

Market Cap

$39.95M

Description

Rafael Holdings, Inc. owns an interest in clinical and early-stage pharmaceutical companies. It operates through the Healthcare and Real Estate segments. The Healthcare segment relates to the activities of LipoMedix, Barer, Farber, and Rafael Medical Devices. The company was founded in 2017 and is headquartered in Newark, NJ.

Metrics

Overview

  • HQNewark, NJ
  • SectorFinance
  • IndustryReal Estate Development
  • TickerRFL
  • Price$1.67+9.15%

Trading Information

  • Market Cap$39.95M
  • Float76.23%
  • Average Daily Volume (1m)18,197
  • Average Daily Volume (3m)24,769
  • EPS-$1.21

Company

  • Revenue$0.54M
  • Rev Growth (1yr)373.24%
  • Net Income-$32.35M
  • Gross Margin44.35%
  • EBITDA Margin-951.79%
  • EBITDA-$3.20M
  • EV-$27.73M
  • EV/Revenue-51.35
  • P/EN/A
  • P/S73.53
Documents